These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35571180)

  • 1. Exploring Key Genes to Construct a Diagnosis Model of Dilated Cardiomyopathy.
    Zheng Y; Liu Z; Yang X; Weng S; Xu H; Guo C; Xing Z; Liu L; Wang L; Dang Q; Qiu C
    Front Cardiovasc Med; 2022; 9():865096. PubMed ID: 35571180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for immune-related biomarkers associated with myasthenia gravis and dilated cardiomyopathy based on bioinformatics analysis and machine learning.
    Zhou G; Wang S; Lin L; Lu K; Lin Z; Zhang Z; Zhang Y; Cheng D; Szeto K; Peng R; Luo C
    Heliyon; 2024 Apr; 10(7):e28446. PubMed ID: 38571624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cuproptosis-related genes and immune infiltration in dilated cardiomyopathy.
    Lin Y; Chen K; Guo J; Chen P; Qian ZR; Zhang T
    Int J Cardiol; 2024 Mar; 399():131702. PubMed ID: 38168558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of risk prediction and neural network models for dilated cardiomyopathy based on WGCNA.
    Yu W; Li L; Tan X; Liu X; Yin C; Cao J
    Front Med (Lausanne); 2023; 10():1239056. PubMed ID: 37869159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative bioinformatics analysis of potential therapeutic targets and immune infiltration characteristics in dilated cardiomyopathy.
    Yang Y; Liu P; Teng R; Liu F; Zhang C; Lu X; Ding Y
    Ann Transl Med; 2022 Mar; 10(6):348. PubMed ID: 35433958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of WGCNA and machine learning identified diagnostic biomarkers in dilated cardiomyopathy with heart failure.
    Zhu Y; Yang X; Zu Y
    Front Cell Dev Biol; 2022; 10():1089915. PubMed ID: 36544902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel algorithm for diagnosis of Arrhythmogenic cardiomyopathy and dilated cardiomyopathy: Key gene expression profiling using machine learning.
    Zhang Y; Xie J; Wu Y; Zhang B; Zhou C; Gao X; Xie X; Li X; Yu J; Wang X; Cheng D; Zhou J; Chen Z; Fan F; Zhou X; Yang B
    J Gene Med; 2023 Mar; 25(3):e3468. PubMed ID: 36518003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of important modules and biomarkers in diabetic cardiomyopathy based on WGCNA and LASSO analysis.
    Cui M; Wu H; An Y; Liu Y; Wei L; Qi X
    Front Endocrinol (Lausanne); 2024; 15():1185062. PubMed ID: 38469146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the communal pathogenesis and immune landscape between viral myocarditis and dilated cardiomyopathy.
    Lei Z; Cao J; Wu J; Lu Y; Ni L; Hu X
    ESC Heart Fail; 2024 Feb; 11(1):282-292. PubMed ID: 37967839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq.
    Fang C; Lv Z; Yu Z; Wang K; Xu C; Li Y; Wang Y
    BMC Cardiovasc Disord; 2022 Jul; 22(1):320. PubMed ID: 35850644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of AC061961.2, LING01-AS1, and RP11-13E1.5 is associated with dilated cardiomyopathy progression.
    Qiu Z; Ye B; Yin L; Chen W; Xu Y; Chen X
    J Cell Physiol; 2019 Apr; 234(4):4460-4471. PubMed ID: 30203513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of key immune-related genes in dilated cardiomyopathy using bioinformatics analysis.
    Li F; Du TY; Wu LD; Zhang L; Liu HH; Zhang ZY; Zhang J; Zhang ZY; Qian LL; Wang RX; Hao JF
    Sci Rep; 2023 Feb; 13(1):1820. PubMed ID: 36725968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential dilated cardiomyopathy-related targets by meta-analysis and co-expression analysis of human RNA-sequencing datasets.
    Yuan Z; Murakoshi N; Xu D; Tajiri K; Okabe Y; Aonuma K; Murakata Y; Li S; Song Z; Shimoda Y; Mori H; Aonuma K; Ieda M
    Life Sci; 2022 Oct; 306():120807. PubMed ID: 35841977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring novel biomarkers in dilated cardiomyopathy‑induced heart failure by integrated analysis and
    Zhou L; Peng F; Li J; Gong H
    Exp Ther Med; 2023 Jul; 26(1):325. PubMed ID: 37346398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential Biomarkers Associated with Dilated Cardiomyopathy by Weighted Gene Coexpression Network Analysis.
    Guo Q; Qu Q; Wang L; Liao S; Zhu X; Du A; Zhu Q; Cheang I; Gao R; Li X
    Front Biosci (Landmark Ed); 2022 Aug; 27(8):246. PubMed ID: 36042172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Verification of Feature Biomarkers Associated With Immune Cells in Dilated Cardiomyopathy by Bioinformatics Analysis.
    Zhu T; Wang M; Quan J; Du Z; Li Q; Xie Y; Lin M; Xu C; Xie Y
    Front Genet; 2022; 13():874544. PubMed ID: 35646094
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of senescence related hub genes and potential therapeutic compounds for dilated cardiomyopathy via comprehensive transcriptome analysis.
    Du C; Wang S; Shi X; Jing P; Wang H; Wang L
    Comput Biol Med; 2024 Sep; 179():108901. PubMed ID: 39029429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Robust Rank Aggregation and Least Absolute Shrinkage and Selection Operator Analysis of Novel Gene Signatures in Dilated Cardiomyopathy.
    Ma X; Mo C; Huang L; Cao P; Shen L; Gui C
    Front Cardiovasc Med; 2021; 8():747803. PubMed ID: 34970603
    [No Abstract]   [Full Text] [Related]  

  • 19. Integrated Bioinformatics Algorithms and Experimental Validation to Explore Robust Biomarkers and Landscape of Immune Cell Infiltration in Dilated Cardiomyopathy.
    Zhang Q; Fan M; Cao X; Geng H; Su Y; Wu C; Pan H; Pan M
    Front Cardiovasc Med; 2022; 9():809470. PubMed ID: 35433865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated genomic analysis defines molecular subgroups in dilated cardiomyopathy and identifies novel biomarkers based on machine learning methods.
    Ye LF; Weng JY; Wu LD
    Front Genet; 2023; 14():1050696. PubMed ID: 36824437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.